Net Cash Provided by (Used in) Operating Activities |
-16K |
USD |
+7.65% |
Q3 2024 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
16K |
USD |
-7.66% |
Q3 2024 |
Q1 2025 |
Common Stock, Shares Authorized |
100M |
shares |
0% |
Q3 2024 |
Q1 2025 |
Common Stock, Shares, Issued |
7.07M |
shares |
0% |
Q3 2024 |
Q1 2025 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2024 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-13 |
USD |
0% |
Q3 2024 |
Q1 2025 |
Deferred Tax Assets, Valuation Allowance |
175K |
USD |
+9.03% |
Q2 2022 |
FY 2022 |
Deferred Tax Assets, Operating Loss Carryforwards |
175K |
USD |
+9.03% |
Q2 2022 |
FY 2022 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2024 |
Q1 2025 |
Preferred Stock, Shares Authorized |
100M |
shares |
0% |
Q3 2024 |
Q1 2025 |
Additional Paid in Capital |
107K |
USD |
0% |
Q3 2024 |
Q1 2025 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2024 |
Q1 2025 |